Drug Administration

Dr. Reddy’s Laboratories announces first-to-market launch of Carboprost Tromethamine Injection USP, 250 mcg/mL (1mL)Single-dose Vial in the U.S. Market

Hyderabad, July 04, 2019: Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, along with its subsidiaries together referred…

5 years ago

Gujarat Based Espee Group gets USFDA Approval for their Manufacturing Plant in USA

New Delhi, February 28, 2019: Aavis Pharmaceuticals, part of Espee Group, located in Hoschton, GA, completed an inspection by the US Food…

6 years ago

Dr. Reddy’s Laboratories launches Tadalafil Tablets USP in the U.S. Market

New Delhi, February 05, 2019: Dr. Reddy’s Laboratories Ltd. ((BSE: 500124, NSE: DRREDDY, NYSE: RDY), along with its subsidiaries together…

6 years ago

Mid-Year FY19 Pharmaceutical Outlook: Outlook Stable Despite Intensifying Profitability Headwinds

New Delhi, September 06, 2018: India Ratings and Research (Ind-Ra) has maintained a stable outlook for the pharmaceutical sector for the…

6 years ago